Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study.
<h4>Background</h4>In clinical practice, the same chemotherapeutic agents are occasionally reused (re-challenge) after failure of all available standard chemotherapy options for metastatic colorectal cancer (mCRC). However, the benefits of re-challenge chemotherapy (Re-Cx) are unclear. T...
Guardado en:
Autores principales: | Masashi Ishikawa, Atsuo Takashima, Yusuke Nagata, Ryoichi Sawada, Masahiko Aoki, Hiroshi Imazeki, Hidekazu Hirano, Hirokazu Shoji, Yoshitaka Honma, Satoru Iwasa, Natsuko Okita, Ken Kato, Masayuki Saruta, Narikazu Boku |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/80f72f9eb44243b8941b7eac292aa720 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Salvage Chemotherapy in Patients with Previously Treated Thymic Carcinoma
por: Kyoichi Kaira, et al.
Publicado: (2021) -
The investigation of salvage endoscopic laryngopharyngeal surgery after chemoradiotherapy
por: Yohei Kawasaki, et al.
Publicado: (2020) -
Salvage surgery for nasopharyngeal cancer
por: Raymond K. Tsang, et al.
Publicado: (2015) -
Salvage of too slow gravitinos
por: I. Antoniadis, et al.
Publicado: (2021) -
Salvaging Exposed Cochlear Implants
por: Khalid Arab, MD, FRCSC, et al.
Publicado: (2021)